Web Results

en.wikipedia.org/wiki/Alefacept

Alefacept is a genetically engineered immunosuppressive drug. It was sold under the brand name Amevive in Canada, the United States, Israel, Switzerland and ...

www.rxlist.com/amevive-drug.htm

Nov 29, 2016 ... Learn about Amevive (Alefacept) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related ...

www.psoriasis.org/media/press-releases/amevive-alefacept-voluntarily-discontinued-us

Nov 16, 2011 ... Astellas Pharma U.S. Inc. (Astellas) has voluntarily discontinued the promotion, manufacturing, distribution and sales of Amevive (alefacept), ...

reference.medscape.com/drug/amevive-alefacept-343188

Medscape - Indication-specific dosing for Amevive (alefacept), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy ...

www.astellas.us/docs/amevive.pdf

AMEVIVE® (alefacept) is an immunosuppressive dimeric fusion protein that consists ... AMEVIVE® for intramuscular injection contains 15 mg alefacept, 12.5 mg ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2386357

Alefacept is the first biological agent approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe chronic plaque psoriasis.

www.accessdata.fda.gov/drugsatfda_docs/label/2005/125036s044lbl.pdf

AMEVIVE® (alefacept) is an immunosuppressive dimeric fusion protein that consists of the ... AMEVIVE® for intramuscular injection contains 15 mg alefacept.

www.medicinenet.com/alefacept/article.htm

Alefacept (Amevive) medication for adults with moderate to severe placuqe psoriasis. Side effects, dosage, pregnancy safety information, and drug interactions.

www.dermnetnz.org/topics/alefacept

Alefacept belongs to the class of biological response modifiers called T-cell blockers. It is currently approved in the US for the treatment of moderate to severe  ...